Published in J Urol on November 01, 1992
RObotic Versus LAparoscopic Resection for Rectal Cancer (ROLARR) | NCT01736072
A Study to Evaluate the Effects of a Prostate Health Formulation | NCT02886832
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol (2013) 4.78
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ (2009) 3.58
Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care. BMJ (2001) 2.71
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol (2007) 2.70
Evaluation of indications for and outcomes of elective surgery. CMAJ (2002) 2.21
Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab (2006) 2.17
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol (2013) 2.16
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys (2005) 2.08
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92
Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol (2009) 1.82
Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol (2007) 1.79
Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med (2011) 1.76
A prospective study of statin drug use and lower urinary tract symptoms in older men. Am J Epidemiol (2013) 1.75
Benign prostatic hyperplasia. Part 1--diagnosis. BMJ (2008) 1.70
The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract (2010) 1.69
Benign prostatic hyperplasia: an overview. Rev Urol (2005) 1.67
Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med (2004) 1.66
Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ (2006) 1.66
Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol (2009) 1.64
Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol (2005) 1.63
Benign prostatic hyperplasia. Br J Gen Pract (1997) 1.60
Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study. Korean J Urol (2010) 1.59
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol (2013) 1.58
2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J (2010) 1.56
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health (2006) 1.53
Lower urinary tract symptoms increase the risk of falls in older men. BJU Int (2009) 1.53
Sex hormones and the risk of incident prostate cancer. Urology (2010) 1.52
Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume. BJU Int (2012) 1.52
The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol (2013) 1.52
Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network. Prostate (2014) 1.49
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol (2008) 1.49
Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology (2008) 1.48
Prospective study of restless legs syndrome and risk of erectile dysfunction. Am J Epidemiol (2013) 1.47
Use of meta-analytic results to facilitate shared decision making. J Am Med Inform Assoc (1999) 1.47
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46
Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging (2013) 1.46
Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men. Urology (2012) 1.44
Physical activity and quality of life after radical prostatectomy. Can Urol Assoc J (2010) 1.44
Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomized controlled trial. Evid Based Complement Alternat Med (2011) 1.44
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis (2011) 1.44
Promising molecular targets and biomarkers for male BPH and LUTS. Curr Urol Rep (2013) 1.43
Alpha-blocker use is associated with decreased risk of sexual dysfunction. Urology (2009) 1.42
Nocturia and overnight polysomnography in Parkinson disease. Neurourol Urodyn (2013) 1.40
Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample. J Urol (2013) 1.40
Personal digital assistant data capture: the future of quality of life measurement in prostate cancer treatment. J Oncol Pract (2007) 1.39
Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study). Asian J Androl (2015) 1.39
Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan. BMC Res Notes (2015) 1.39
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) (2011) 1.38
Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey. Neurourol Urodyn (2012) 1.38
Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med (2013) 1.38
Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence: Study Protocol of a Pilot Multicentered, Randomized, Parallel, Sham-Controlled Trial. Evid Based Complement Alternat Med (2016) 1.38
Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community. Urology (2009) 1.37
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
Is abuse causally related to urologic symptoms? Results from the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 1.29
Can a urinary tract symptom score predict the development of postoperative urinary retention in patients undergoing lower limb arthroplasty under spinal anaesthesia? A prospective study. Ann R Coll Surg Engl (2006) 1.29
A systematic evaluation of factors associated with nocturia--the population-based FINNO study. Am J Epidemiol (2009) 1.29
On what basis should the effectiveness of decision aids be judged? Health Expect (2003) 1.27
Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol (2004) 1.27
Dropout in a longitudinal, cohort study of urologic disease in community men. BMC Med Res Methodol (2006) 1.24
Progression of lower urinary tract symptoms in older men: a community based study. J Urol (2010) 1.22
Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation (2013) 1.20
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol (2009) 1.18
Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. J Urol (2012) 1.16
Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol (2007) 1.14
Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population. Urol Res (2004) 1.14
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.12
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2010) 1.11
Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey. World J Mens Health (2012) 1.11
Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. CMAJ (1999) 1.11
Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol (2011) 1.10
Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol (2009) 1.09
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology (2009) 1.09
ProsCan for Couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer (2008) 1.07
Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care (2013) 1.06
The prevalence of lower urinary tract symptoms in korean men aged 40 years or older: a population-based survey. Int Neurourol J (2014) 1.04
Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer (2008) 1.04
Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. J Clin Endocrinol Metab (2010) 1.04
Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up study. BMC Med (2011) 1.03
A study of bladder dysfunction in women with type 2 diabetes mellitus. Indian J Endocrinol Metab (2014) 1.03
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov (2014) 1.03
Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol (2006) 1.02
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet (2015) 1.02
Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J Urol (2011) 1.01
Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy. Can Urol Assoc J (2009) 1.01
Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. J Gen Intern Med (1997) 1.01
Recreational urethral sounding is associated with high risk sexual behaviour and sexually transmitted infections. BJU Int (2012) 1.01
Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J Urol (2013) 1.01
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate (2008) 1.00
Histotripsy methods in mechanical disintegration of tissue: towards clinical applications. Int J Hyperthermia (2015) 0.99
Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology (2007) 0.99
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Cancer Biol Ther (2011) 0.98
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol (2011) 0.98
Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia. Urology (2011) 0.98
Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes (2014) 0.98
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med (1992) 7.16
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med (1998) 6.44
Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol (1989) 4.76
Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care (1995) 4.25
The interstitial cystitis symptom index and problem index. Urology (1997) 3.97
The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med (1996) 3.87
Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. JAMA (1988) 3.73
A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med (1995) 3.38
How common is prostatitis? A national survey of physician visits. J Urol (1998) 2.90
A brief male sexual function inventory for urology. Urology (1995) 2.80
Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol (1974) 2.61
The use of cognitive testing to develop and evaluate CAHPS 1.0 core survey items. Consumer Assessment of Health Plans Study. Med Care (1999) 2.57
An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA (1988) 2.42
Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol (1993) 2.06
Peritonitis and abdominal free air due to intraperitoneal bladder perforation associated with indwelling urethral catheter drainage. J Urol (1985) 1.94
Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol (1993) 1.91
Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care (1995) 1.88
The effect of a shared decisionmaking program on rates of surgery for benign prostatic hyperplasia. Pilot results. Med Care (1995) 1.86
Transurethral prostatectomy in the azotemic patient. J Urol (1974) 1.78
The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol (1994) 1.72
Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med (2001) 1.64
Animal model studies of genital chlamydial infections. Immunity to re-infection with guinea-pig inclusion conjunctivitis agent in the urethra and eye of male guinea-pigs. Br J Vener Dis (1976) 1.61
Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol (1988) 1.59
The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol (1994) 1.56
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care. J Urol (2000) 1.56
Controversies about indications for transurethral resection of the prostate. J Urol (1989) 1.56
A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. Arch Fam Med (1993) 1.54
Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology (1998) 1.48
Long-term experience with pentosanpolysulfate in interstitial cystitis. Urology (1998) 1.48
Analysis of variation in prostate-specific antigen values. Urology (1993) 1.45
Subspecialization, recruitment and retirement trends of American urologists. J Urol (1998) 1.41
Reproducibility of pressure-flow variables in patients with symptomatic benign prostatic hyperplasia. Urology (1995) 1.39
The will to live among HIV-infected patients. Ann Intern Med (1999) 1.35
Discussion of preferences for life-sustaining care by persons with AIDS. Predictors of failure in patient-physician communication. Arch Intern Med (1993) 1.35
A test of consumer contribution to small area variations in health care delivery. J Maine Med Assoc (1977) 1.31
Comparing prospective and retrospective measures of treatment outcomes. Med Care (1995) 1.27
Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin (1994) 1.27
Neuroendocrine differentiation in prostatic malignancy. Cancer (1996) 1.24
Do physicians do what they say? The inclination to test and its association with coronary angiography rates. J Gen Intern Med (1997) 1.22
Improved localization and survival in patients with intraabdominal abscesses. Am J Surg (1983) 1.21
Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res (2006) 1.20
Providing consumers with information about the quality of health plans: the Consumer Assessment of Health Plans demonstration in Washington State. Jt Comm J Qual Improv (2000) 1.19
Comprehensive patient evaluation for benign prostatic hyperplasia. Urology (1998) 1.17
Transurethral prostatectomy: immediate and postoperative complications. a cooperative study of 13 participating institutions evaluating 3,885 patients. 1989. J Urol (2002) 1.17
Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis. Invest Urol (1967) 1.17
3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol (1986) 1.15
Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol (1989) 1.15
The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol (1995) 1.15
Living related and unrelated donors for kidney transplantation. A 28-year experience. Ann Surg (1995) 1.15
Significance of testicular size measurement in andrology: II. Correlation of testicular size with testicular function. J Urol (1987) 1.14
Pathophysiology of bends and decompression sickness. An overview with emphasis on treatment. Arch Surg (1979) 1.13
Analysis and management of chronic testicular pain. J Urol (1990) 1.13
Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care (1993) 1.12
Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate (1993) 1.12
Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology (1996) 1.12
The influence of interviewer and respondent psychological and behavioral variables on the reporting in household interviews. Vital Health Stat 2 (1968) 1.10
Analysis of presenting symptoms in prostatism. J Urol (1984) 1.09
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group. Eur Urol (2000) 1.09
The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol (1997) 1.08
Endoscopic transrectal resection of rectal carcinomas using the urologic resectoscope. Dis Colon Rectum (1984) 1.08
The Consumer Assessment of Health Plan Study (CAHPS) survey of children's health care. Jt Comm J Qual Improv (1999) 1.08
Percutaneous nephropyelostomy in the management of acute pyohydronephrosis. Radiology (1976) 1.08
The varicocele. Fertil Steril (1984) 1.08
A comparison of subjective measurements of human sperm motility and viability with two live-dead staining techniques. Fertil Steril (1975) 1.06
Histological changes occurring in the contralateral testes of prepubertal rats subjected to various durations of unilateral spermatic cord torsion. J Urol (1985) 1.05
Structure and function of the epididymis. Urol Res (1986) 1.04
The stability of preferences for life-sustaining care among persons with AIDS in the Boston Health Study. Med Decis Making (1999) 1.03
Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology (1998) 1.02
Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology (1994) 1.02
World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol (1991) 1.01
Vasovasostomy: current state of the art. Urology (1983) 1.01
Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. J Gen Intern Med (1997) 1.01